Results 201 to 210 of about 185,979 (321)
Portopulmonary hypertension practice patterns after liver transplantation
Liver Transplantation, EarlyView., 2022 Abstract
Portopulmonary hypertension (POPH) is a type of pulmonary arterial hypertension occurring exclusively in those with portal hypertensive liver disease. Liver transplantation (LT) can significantly improve outcomes. Current guidelines counsel against immediate adjustments to targeted therapy after LT and suggest routine echocardiography as ...Arun Jose, Elizabeth J. Kopras, Shimul A. Shah, Jean M. Elwing +3 morewiley +1 more sourceDomino heart transplant following heart-lung transplantation: a systematic review and meta-analysis. [PDF]
Ann Cardiothorac Surg, 2020 Maynes EJ, O'Malley TJ, Austin MA, Deb AK, Choi JH, Weber MP, Khaghani A, Massey HT, Daly RC, Tchantchaleishvili V. +9 moreeuropepmc +1 more sourceLongitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984–2006
, 2015 Renhua Na, Maarit A. Laaksonen, Andrew E. Grulich, Angela C Webster, Nicola S. Meagher, Geoffrey W. McCaughan, Anne Keogh, Claire M. Vajdic +7 moreopenalex +2 more sourcesAmerican College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel
Arthritis &Rheumatology, EarlyView.Objective
Vacuoles E1 enzyme X‐linked autoinflammatory somatic syndrome (VEXAS) is a recently identified rare genetic disorder associated with somatic mutations in the UBA1 gene. VEXAS presents with a combination of inflammatory and hematologic manifestations, leading to increased morbidity and mortality.Arsene Mekinian, Sophie Georgin‐Lavialle, Marcela A. Ferrada, Sinisa Savic, Matthew J. Koster, Olivier Kosmider, Thibault Comont, Mael Heilblig, Juan I. Arostegui, Annmarie Bosco, Rim Bourguiba, Katherine R. Calvo, Catherine Cargo, Chiara Cattaneo, François Chasset, Henrique Coelho, Corrado Campochiaro, Francesca Crisafulli, Stephanie Ducharme‐Benard, Raquel Faria, Franco Franceschini, Micol Frassi, Emma M. Groarke, Carmelo Gurnari, Yervand Hakobyan, Yvan Jamilloux, Ciprian Jurcut, Yohei Kirino, Austin Kulasekararaj, Hiroyoshi Kunimoto, Lauren M. Madigan, Heřman F. Mann, Chiara Marvisi, Marcin Milchert, Sara Morais, Katja Sockel, Francesco Muratore, Hideaki Nakajima, Mrinal M. Patnaik, Luísa Regadas, Marie Robin, Abraham Rutgers, Carlo Salvarani, Anthony M. Sammel, Joerg Seebach, Pierre Sujobert, Alessandro Tomelleri, Geoffrey Urbanski, Frédéric Vandergheynst, Romana Vieira, David S. Viswanatha, Ewa Więsik‐Szewczyk, Elisa Diral, Benjamin Terrier, Bhavisha A. Patel, Pierre Fenaux, Peter C. Grayson, David B. Beck, on behalf of the International VEXAS working group, and with endorsement of EuroBloodNet, the European Reference Network in Rare Hematological Diseases, Heřman Mann, Benjamin Terrier, François Chasset, Sophie Georgin Lavialle, Alessandro Tomelleri, Campochiaro Corrado, Carlo Salvarani, Francesca Crisafulli, Franco Franceschini, Micol Frassi, Yohei Kirino, Ewa Więsik‐Szewczyk, Marcin Milchert, Raquel Faria, Ciprian Jurcut, Joerg Seebach, Sinisa Savic, David Beck, Lauren Madigan, Matthew Koster, Patnaik Mrinal, Olivier Kosmider, Pierre Sujobert, Juan I. Arostegui, Catherine Cargo, David Viswanatha, Yervand Hagopian, Mael Heilblig, Pierre Fenaux, Thibault Comont, Bruno Alessandro, Chiara Cattaneo, Elisa Diral, Sara Morais, Austin Kulasekarara, Emma Groarke, Katherine Calvo, Patel Bhavisha, Anthony Sammel, Arsene Mekinian, Benjamin Terrier, Marie Robin, Sophie Georgin Lavialle, Katja Sockel, Yvan Jamilloux, Carmelo Gurnari, Henrique Coelho, Romana Vieira, Rim Bourguiba, Marcela Ferrada, Peter Grayson +111 morewiley +1 more sourceFour decades of heart-lung transplantation: Milestones and outcomes in advanced cardiorespiratory failure. [PDF]
ESC Heart FailRosenthal LL, Mühlbauer AM, Grinninger C, Haas NA, Netz H, Pozza RD, Hörer J, Michel S, Schramm R, Graetz D, Hagl C. +10 moreeuropepmc +1 more sourceCase‐Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease
Arthritis &Rheumatology, EarlyView.Interstitial lung disease (ILD) is an important complication of systemic sclerosis (SSc), with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to US Food and Drug Administration–approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of ILDs of other systemic autoimmune Nina Goldman, Voon Ong, Christopher P. Denton +2 morewiley +1 more sourceRenal Outcomes After Lung or Combined Heart-Lung Transplantation in Pulmonary Hypertension. [PDF]
Pulm CircHardy L, D'Haenens A, Belmans A, Quarck R, Aerts G, Belge C, Claessen G, Kuypers D, De Vlieger G, Verbelen T, Ceulemans LJ, Van Raemdonck DE, Vanaudenaerde BM, Verleden G, Dupont L, Vos R, Delcroix M, Godinas L. +17 moreeuropepmc +1 more source
